|
Eli Lilly and Co
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$987
|
$966B |
15.2x |
33.5x |
|
Johnson & Johnson
|
United States of America |
Biopharmaceuticals,
Medical Devices,
Drug Development & Therapeutics
|
$242
|
$612B |
6.5x |
17.1x |
|
AbbVie
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Health & Beauty
|
$232
|
$472B |
7.7x |
18.1x |
|
Roche
|
Switzerland |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Imaging & Diagnostics
|
CHF 361
|
$398B |
4.9x |
12.5x |
|
AstraZeneca
|
United Kingdom of Great Britain and Northern Ireland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
£151
|
$345B |
5.8x |
16.7x |
|
Novartis
|
Switzerland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CHF 125
|
$335B |
5.9x |
14.2x |
|
Merck & Co
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$122
|
$327B |
5.0x |
11.0x |
|
Amgen
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$375
|
$247B |
6.8x |
14.0x |
|
Novo Nordisk
|
Denmark |
Biopharmaceuticals,
Drug Development & Therapeutics
|
DKK 311
|
$237B |
4.8x |
10.0x |
|
Gilead Sciences
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$155
|
$210B |
7.2x |
13.1x |
|
Pfizer
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$27
|
$197B |
3.2x |
8.0x |
|
Bristol-Myers Squibb
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$61
|
$160B |
3.3x |
8.6x |
|
GSK
|
United Kingdom of Great Britain and Northern Ireland |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
£22
|
$138B |
3.1x |
9.2x |
|
Sanofi
|
France |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
€78
|
$127B |
2.4x |
7.9x |
|
Vertex Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Regenerative Medicine
|
$491
|
$120B |
10.0x |
22.2x |
|
Chugai Pharmaceutical Co
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 9280
|
$91.5B |
11.5x |
22.6x |
|
Bayer
|
Germany |
Biopharmaceuticals,
Agriculture,
Drug Development & Therapeutics,
Health & Beauty
|
€44
|
$89.9B |
1.7x |
7.9x |
|
Takeda Pharmaceuticals
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 5614
|
$83.0B |
2.9x |
10.6x |
|
Merck KGaA
|
Germany |
Biopharmaceuticals,
Drug Development & Therapeutics,
Advanced Materials
|
€128
|
$77.1B |
3.1x |
10.6x |
|
CSL
|
Australia |
Biopharmaceuticals,
Vaccines & Immunotherapies
|
AUD 152
|
$62.1B |
3.6x |
10.8x |
|
Zoetis
|
United States of America |
Pet Care,
Biopharmaceuticals,
Drug Development & Therapeutics
|
$127
|
$60.4B |
6.4x |
14.7x |
|
Lonza Group
|
Switzerland |
Contract Research & Manufacturing,
Biopharmaceuticals
|
CHF 536
|
$53.5B |
5.4x |
18.5x |
|
Teva Pharmaceuticals
|
Israel |
Biopharmaceuticals,
Drug Development & Therapeutics
|
ILS 104
|
$53.0B |
3.0x |
10.1x |
|
Jiangsu Hengrui Pharma
|
Hong Kong |
Biopharmaceuticals
|
HKD 66
|
$50.2B |
10.8x |
36.1x |
|
Jiangsu Hengrui Pharma
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 58
|
$50.1B |
10.5x |
34.8x |
|
Sun Pharma
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1698
|
$42.2B |
6.8x |
23.9x |
|
Sandoz
|
Switzerland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CHF 66
|
$41.2B |
3.6x |
16.7x |
|
Celltrion
|
South Korea |
Biopharmaceuticals
|
KRW 244500
|
$38.0B |
13.4x |
37.4x |
|
Otsuka Holdings
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics,
Nutraceuticals & Cosmeceuticals
|
JPY 10585
|
$33.6B |
2.2x |
8.9x |
|
Daiichi Sankyo
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 2937
|
$32.4B |
2.5x |
12.2x |
|
Viatris
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$16
|
$31.7B |
2.2x |
7.7x |
|
Astellas Pharma
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 2511
|
$31.7B |
2.5x |
10.4x |
|
Biogen
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$197
|
$31.6B |
3.2x |
10.4x |
|
Royalty Pharma
|
United States of America |
Biopharmaceuticals
|
$45
|
$26.8B |
9.0x |
9.2x |
|
Hansoh Pharma
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 37
|
$24.0B |
11.4x |
29.7x |
|
Bausch Health
|
Canada |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Devices,
Health & Beauty
|
CAD 8
|
$21.9B |
2.1x |
6.0x |
|
Innovent Biologics
|
Hong Kong |
Drug Development & Therapeutics,
Biopharmaceuticals
|
HKD 91
|
$19.1B |
9.9x |
109.7x |
|
Grifols
|
Spain |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€10
|
$18.0B |
2.0x |
8.3x |
|
Sobi
|
Sweden |
Biopharmaceuticals,
Drug Development & Therapeutics
|
SEK 408
|
$17.0B |
5.3x |
13.8x |
|
Sichuan Biokin
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 287
|
$16.8B |
52.5x |
N/A |
|
Shionogi
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Devices
|
JPY 3536
|
$15.6B |
5.0x |
12.5x |
|
Genmab
|
Denmark |
Drug Development & Therapeutics,
Biopharmaceuticals
|
DKK 1904
|
$15.4B |
4.1x |
10.9x |
|
Torrent Pharmaceuticals
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 4078
|
$15.4B |
11.1x |
33.6x |
|
Alteogen
|
South Korea |
Biopharmaceuticals
|
KRW 411500
|
$14.8B |
96.3x |
179.4x |
|
Ipsen
|
France |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€155
|
$14.5B |
3.2x |
8.5x |
|
Sino Biopharmaceutical
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 7
|
$14.1B |
2.9x |
11.0x |
|
Recordati
|
Italy |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€48
|
$14.1B |
4.5x |
12.0x |
|
CSPC Pharma Group
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 11
|
$14.0B |
3.5x |
14.1x |
|
Fosun Pharma
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Devices
|
CNY 25
|
$12.9B |
2.2x |
13.5x |
|
Zhejiang NHU
|
China |
Biopharmaceuticals,
Nutraceuticals & Cosmeceuticals
|
CNY 29
|
$12.9B |
3.8x |
9.0x |
|
Yunnan Baiyao Group
|
China |
Biopharmaceuticals,
Health & Beauty
|
CNY 56
|
$12.7B |
2.1x |
14.3x |
|
Financiere de Tubize
|
Belgium |
Biopharmaceuticals
|
€238
|
$12.6B |
N/A |
N/A |
|
Akeso
|
Hong Kong |
Drug Development & Therapeutics,
Biopharmaceuticals
|
HKD 109
|
$12.5B |
26.5x |
-1246.4x |
|
Kelun-Biotech
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 417
|
$11.8B |
42.3x |
-255.8x |
|
CR Pharmaceutical
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics,
Pharmacies
|
HKD 5
|
$11.8B |
0.3x |
5.0x |
|
Neurocrine Biosciences
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$128
|
$11.8B |
4.1x |
17.8x |
|
Orion
|
Finland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€68
|
$11.5B |
5.1x |
13.8x |
|
Dr. Reddy's Laboratories
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1268
|
$11.5B |
3.1x |
12.5x |
|
Lupin
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 2199
|
$11.0B |
4.0x |
15.5x |
|
Cipla
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1331
|
$10.7B |
3.4x |
14.0x |
|
Zydus Lifesciences
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 905
|
$10.3B |
3.7x |
13.4x |
|
Halozyme Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$79
|
$10.2B |
7.6x |
11.6x |
|
Organon
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$7
|
$10.1B |
1.6x |
5.2x |
|
Wuxi XDC
|
Hong Kong |
Contract Research & Manufacturing,
Biopharmaceuticals
|
HKD 65
|
$10.0B |
11.7x |
38.3x |
|
Mankind Pharma
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics,
Health & Beauty
|
INR 2060
|
$9.9B |
6.4x |
25.7x |
|
Abivax
|
France |
Drug Development & Therapeutics,
Biopharmaceuticals
|
€106
|
$9.3B |
905.1x |
-38.4x |
|
Huadong Medicine
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 36
|
$8.8B |
1.4x |
11.0x |
|
Eisai Co.
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 5066
|
$8.6B |
1.7x |
13.6x |
|
Praxis Precision Medicines
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$317
|
$8.5B |
28552.0x |
-28.7x |
|
Biocon
|
India |
Biopharmaceuticals,
Contract Research & Manufacturing
|
INR 378
|
$7.8B |
4.2x |
20.3x |
|
Krka
|
Slovenia |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€235
|
$7.8B |
3.3x |
9.8x |
|
Kyowa Kirin Co
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 2691
|
$7.6B |
2.5x |
10.9x |
|
RemeGen
|
Hong Kong |
Biopharmaceuticals
|
HKD 102
|
$7.5B |
18.4x |
-3072.9x |
|
Lundbeck
|
Denmark |
Biopharmaceuticals,
Drug Development & Therapeutics
|
DKK 38
|
$7.4B |
N/A |
N/A |
|
ABL Bio
|
South Korea |
Biopharmaceuticals,
Drug Development & Therapeutics
|
KRW 194600
|
$7.3B |
93.5x |
16374.8x |
|
Ono Pharmaceutical
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 2536
|
$7.2B |
2.3x |
9.5x |
|
Aurobindo Pharma
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1146
|
$7.2B |
2.0x |
9.6x |
|
Amneal Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$15
|
$7.1B |
2.4x |
10.5x |
|
PharmaEssentia
|
Taiwan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
TWD 725
|
$7.0B |
14.5x |
43.7x |
|
Alkem Laboratories
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics,
Nutraceuticals & Cosmeceuticals
|
INR 5403
|
$6.8B |
4.4x |
21.8x |
|
3SBio
|
Hong Kong |
Biopharmaceuticals
|
HKD 24
|
$6.6B |
2.5x |
3.6x |
|
China Resources Sanjiu
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 29
|
$6.5B |
1.5x |
8.6x |
|
Gedeon Richter
|
Hungary |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HUF 11700
|
$6.4B |
2.2x |
5.9x |
|
Belite Bio
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$174
|
$6.2B |
N/A |
N/A |
|
Bachem
|
Switzerland |
Chemicals,
Biopharmaceuticals
|
CHF 64
|
$6.2B |
6.9x |
24.0x |
|
Shanghai RAAS
|
China |
Biopharmaceuticals
|
CNY 6
|
$6.1B |
N/A |
N/A |
|
Hikma Pharmaceuticals
|
United Kingdom of Great Britain and Northern Ireland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
£16
|
$6.1B |
1.8x |
7.1x |
|
Hebei Changshan
|
China |
Biopharmaceuticals
|
CNY 43
|
$6.1B |
N/A |
N/A |
|
Glenmark Pharma
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1997
|
$6.0B |
3.4x |
22.8x |
|
Abbott India
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Devices,
Nutraceuticals & Cosmeceuticals
|
INR 26470
|
$6.0B |
8.0x |
29.1x |
|
Dottikon ES Holding
|
Switzerland |
Chemicals,
Biopharmaceuticals
|
CHF 335
|
$5.9B |
N/A |
N/A |
|
Imeik Technology Development
|
China |
Biopharmaceuticals
|
CNY 145
|
$5.9B |
16.2x |
24.1x |
|
Yuhan
|
South Korea |
Biopharmaceuticals,
Drug Development & Therapeutics
|
KRW 112657
|
$5.7B |
3.8x |
42.6x |
|
Hanmi Pharm
|
South Korea |
Biopharmaceuticals,
Drug Development & Therapeutics
|
KRW 621000
|
$5.5B |
5.3x |
24.5x |
|
Henlius Biotech
|
Hong Kong |
Biopharmaceuticals
|
HKD 72
|
$5.4B |
6.4x |
32.6x |
|
Cogent Biosciences
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$37
|
$5.4B |
N/A |
-20.0x |
|
Aspen Pharmacare
|
South Africa |
Biopharmaceuticals,
Drug Development & Therapeutics
|
ZAR 124
|
$5.3B |
2.0x |
11.3x |
|
Gan and Lee
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 65
|
$5.2B |
8.5x |
25.5x |
|
Celcuity
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$107
|
$4.8B |
N/A |
-29.1x |
|
Changchun High-Tech
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 87
|
$4.8B |
2.4x |
9.1x |